SlideShare a Scribd company logo
APPROACH TO PRIMARY OPEN
ANGLE GLAUCOMA
Presenter : Dr. Divya Kesarwani
DEFINITION
Primary open-angle glaucoma (POAG) can be considered as
Chronic, progressive, anterior optic neuropathy
Characteristic cupping and atrophy of the optic disc,
 Visual field loss,
Open angles,
 No obvious causative ocular or systemic conditions
 IOP elevated above statistically ‘normal’ range in majority but not all
cases.
Risk Factors
• IOP
• Age/Gender
• Race
• Refractive Error
• Corneal Thickness
• Heredity and Genetics
• Systemic Factors
Dx: HISTORY
Visual symptoms: Early stages mostly asymptomatic
 Late stages Tubular vision is retained, Temporal field loss  central
fixation loss.
H/o myopia, trauma, inflammation, previous eye Sx/ refractive Sx.
Family H/o of POAG / any other ocular ds..
T/t H/o steroids or oral B blockers.
H/o smoking/alcohol/ any drug allergy.
Past Medical H/o
 Asthma, heart ds, PVD  CI’s to the use of B-blockers.
Head injury, intracranial ds, stroke  optic atrophy or visual field defects.
Migraine and Raynaud phenomenon  vasospasm
Diabetes, HTN and CVS ds  risk of POAG
EXAMINATION
 Visual acuity
 Pupils : RAPD
 SLE
 Tonometry
 Gonioscopy.
 Optic disc examination: intrapapillary changes
 Peripapillary changes : PPA, RNFL defects, Disc splinter H’ages, diameter of
retinal arterioles.
Evaluationof opticnerve head
The optic disk size and shape,
 Cup-to-disk (C:D) ratio in relation to the disk size,
Configuration and depth of the optic cup,
The configuration of the neuroretinal rim,
Position of the exit of the central retinal vessel trunk,
Presence and location of disk hemorrhage,
 RNFL defects, and
Configuration and location of parapapillary chorioretinal atrophy
The Neuroretinal Rim
• Most important parameter.
• This is the ‘ISNT rule’ which helps to determine glaucomatous changes in the
disc glaucoma.
• On an average, the inferior rim is 18% thicker than the superior rim.*
• The loss of NRR from the inner edge of the rim cardinal feature.
• The sequence of loss is usually first in the inferotemporal and superotemporal disk
regions.
• *Arvind H, George R, Raju P, Ve RS, Mani B, Kannan P, Vijaya L. Neural rim characteristics of healthy South Indians: the Chennai Glaucoma
Study. Invest Ophthalmol Vis Sci 2008 Aug;49(8):
3457-3464
Optic disc haemorrhage
• Splinter or flame-shaped hemorrhage, with feathered edges,
oriented radially and perpendicular to the disk margin.
• Location: prelaminar area of the optic disk and in the adjacent
superficial RNFL.
• It is located within one disk diameter from the optic disk border
Retinal Nerve Fibre Layer
• Red-free light is best for evaluation of the RNFL as the
short wavelength light brings the anterior layer into better
focus.
• The classic localised defect of the RNFL associated with
glaucoma is seen as a darkened wedge that extends from a
corresponding thinning in the neuroretinal rim tissue
Peripapillary ChorioretinalAtrophy
• The peripheral alpha zone : Irregular hypo- and hyperpigmentation,
associated with thinning of the chorioretinal tissue layer.
• Bthe cenral beta zone : marked atrophy of the RPE and choriocapillaris
and thinning of the chorioretinal tissues with good visibility of the large
choroidal vessels and sclera.
• If both zones are present, the beta zone is always closer to the optic disc
than the alpha zone.
INVESTIGATIONS
• Pachymetry
• Perimetry
• Ocular coherence tomography(OCT): optic disc and peripapillar
RNFL imaging
• Fundus photograph
DIFFERENTIAL DIAGNOSIS
Other causes of increased IOP
Ocular hypertension
Secondary open angle glaucoma
Chronic angle closure glaucoma
Other causes of cupping and field defects
Physiological cupping
Congenital optic nerve defects
Anterior ischemic optic neuropathy
Primary optic atophy
TREATMENT
INDICATIONS
1) Classic glaucoma triad or at high risk for same.
2) Progressive cupping without detectable field loss,
3) The development of visual field loss,
4) Episodes of corneal edema caused by elevated IOP,
5) Vascular occlusion associated increased IOP.
6) C/L eye in pts with asymmetric POAG  treated aggressively 
40% chance of v. field loss over a 5-year .
GOALS
To preserve good visual function for the patient’s lifetime.
To preserve a reasonable quality of life and comfort.
 Minimizing the side effects from the treatment, the risk of vision
loss and, in many cases, the costs associated with treatment.
TARGET PRESSURE
Definition : The pressure level (range) below which further
damage to the optic nerve is unlikely to occur.
Choice of target IOP:
It is usually 20-30 % reduction of baseline IOP
but it should be individualized for each patient based on
1.Initial untreated IOP.
2.Degree of existing damage.(Optic nerve cupping, visual field loss
and RNFL thickness)
3. Age of the patient (life expectancy)
Follow-up and Resetting target IOP
Target IOP is a dynamic value.
The initial efficacy of therapy is determined by its effect on
IOP, but long-term efficacy must be determined by the analysis
of damage (visual field, the optic nerve head, retinal nerve fiber
thickness).
Deterioration in any of these  more aggressive T/t
(i.e. to Re-set the Target intraocular pressure at a lower level) taking
into consideration the other risk factors
THANK YOU 

More Related Content

Similar to PRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptx

Clinical approach to acute vision loss
Clinical approach to acute vision loss  Clinical approach to acute vision loss
Clinical approach to acute vision loss
neurophq8
 
Optic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaOptic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaDr Laltanpuia Chhangte
 
Normal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptxNormal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptx
Azizul Islam
 
AION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic NeuropathyAION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic Neuropathy
Noor Munirah Aab
 
Glaucoma 2nd class
Glaucoma 2nd classGlaucoma 2nd class
Glaucoma 2nd class
DrAliReja
 
Normal tension glaucoma
Normal tension glaucomaNormal tension glaucoma
Normal tension glaucoma
Laxmi Eye Institute
 
Optic Disc Abnormalities and their presentations
Optic Disc Abnormalities and their presentationsOptic Disc Abnormalities and their presentations
Optic Disc Abnormalities and their presentations
BARNABASMUGABI
 
Introduction to glaucoma.pptx
Introduction to glaucoma.pptxIntroduction to glaucoma.pptx
Introduction to glaucoma.pptx
Mutahir Shah
 
Funduscopy evaluation in glaucomatous optic
Funduscopy evaluation in glaucomatous opticFunduscopy evaluation in glaucomatous optic
Funduscopy evaluation in glaucomatous optic
rikhaerina
 
Optic neuritis treatment trial
Optic neuritis treatment trialOptic neuritis treatment trial
Optic neuritis treatment trial
Vinitkumar MJ
 
14. Primary glaucoma.pptx
14. Primary glaucoma.pptx14. Primary glaucoma.pptx
14. Primary glaucoma.pptx
Annie Amjad
 
14. Primary glaucoma.pptx
14. Primary glaucoma.pptx14. Primary glaucoma.pptx
14. Primary glaucoma.pptx
annieamjad1
 
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal SurgeryIschemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
nsahmedod
 
primaary open angle glaucoma presentation
primaary open angle glaucoma presentationprimaary open angle glaucoma presentation
primaary open angle glaucoma presentation
SandeepKrishnan42
 
Approach to Neurological causes of Vision loss.pptx
Approach to Neurological causes of Vision loss.pptxApproach to Neurological causes of Vision loss.pptx
Approach to Neurological causes of Vision loss.pptx
NeurologyKota
 
Glaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptxGlaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptx
yashabandil155
 
glaucoma and cataract.pdf
glaucoma and cataract.pdfglaucoma and cataract.pdf
glaucoma and cataract.pdf
JishaSrivastava
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
alijafer99
 
Myopia
Myopia Myopia
Ischemic optic neuropathy
Ischemic optic neuropathyIschemic optic neuropathy
Ischemic optic neuropathy
16divya
 

Similar to PRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptx (20)

Clinical approach to acute vision loss
Clinical approach to acute vision loss  Clinical approach to acute vision loss
Clinical approach to acute vision loss
 
Optic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucomaOptic nerve head evaluation in glaucoma
Optic nerve head evaluation in glaucoma
 
Normal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptxNormal Tension Glaucoma.pptx
Normal Tension Glaucoma.pptx
 
AION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic NeuropathyAION Anterior Ischemic Optic Neuropathy
AION Anterior Ischemic Optic Neuropathy
 
Glaucoma 2nd class
Glaucoma 2nd classGlaucoma 2nd class
Glaucoma 2nd class
 
Normal tension glaucoma
Normal tension glaucomaNormal tension glaucoma
Normal tension glaucoma
 
Optic Disc Abnormalities and their presentations
Optic Disc Abnormalities and their presentationsOptic Disc Abnormalities and their presentations
Optic Disc Abnormalities and their presentations
 
Introduction to glaucoma.pptx
Introduction to glaucoma.pptxIntroduction to glaucoma.pptx
Introduction to glaucoma.pptx
 
Funduscopy evaluation in glaucomatous optic
Funduscopy evaluation in glaucomatous opticFunduscopy evaluation in glaucomatous optic
Funduscopy evaluation in glaucomatous optic
 
Optic neuritis treatment trial
Optic neuritis treatment trialOptic neuritis treatment trial
Optic neuritis treatment trial
 
14. Primary glaucoma.pptx
14. Primary glaucoma.pptx14. Primary glaucoma.pptx
14. Primary glaucoma.pptx
 
14. Primary glaucoma.pptx
14. Primary glaucoma.pptx14. Primary glaucoma.pptx
14. Primary glaucoma.pptx
 
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal SurgeryIschemic Optic Neuropathy: A Sequala of Spinal Surgery
Ischemic Optic Neuropathy: A Sequala of Spinal Surgery
 
primaary open angle glaucoma presentation
primaary open angle glaucoma presentationprimaary open angle glaucoma presentation
primaary open angle glaucoma presentation
 
Approach to Neurological causes of Vision loss.pptx
Approach to Neurological causes of Vision loss.pptxApproach to Neurological causes of Vision loss.pptx
Approach to Neurological causes of Vision loss.pptx
 
Glaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptxGlaucoma-Presentation new.pptx
Glaucoma-Presentation new.pptx
 
glaucoma and cataract.pdf
glaucoma and cataract.pdfglaucoma and cataract.pdf
glaucoma and cataract.pdf
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
 
Myopia
Myopia Myopia
Myopia
 
Ischemic optic neuropathy
Ischemic optic neuropathyIschemic optic neuropathy
Ischemic optic neuropathy
 

Recently uploaded

GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
University of Maribor
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
moosaasad1975
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 

Recently uploaded (20)

GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.What is greenhouse gasses and how many gasses are there to affect the Earth.
What is greenhouse gasses and how many gasses are there to affect the Earth.
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 

PRIMARY OPEN ANGLE GLAUCOMA - Copy (2).pptx

  • 1. APPROACH TO PRIMARY OPEN ANGLE GLAUCOMA Presenter : Dr. Divya Kesarwani
  • 2. DEFINITION Primary open-angle glaucoma (POAG) can be considered as Chronic, progressive, anterior optic neuropathy Characteristic cupping and atrophy of the optic disc,  Visual field loss, Open angles,  No obvious causative ocular or systemic conditions  IOP elevated above statistically ‘normal’ range in majority but not all cases.
  • 3. Risk Factors • IOP • Age/Gender • Race • Refractive Error • Corneal Thickness • Heredity and Genetics • Systemic Factors
  • 4.
  • 5.
  • 6. Dx: HISTORY Visual symptoms: Early stages mostly asymptomatic  Late stages Tubular vision is retained, Temporal field loss  central fixation loss. H/o myopia, trauma, inflammation, previous eye Sx/ refractive Sx. Family H/o of POAG / any other ocular ds.. T/t H/o steroids or oral B blockers. H/o smoking/alcohol/ any drug allergy. Past Medical H/o  Asthma, heart ds, PVD  CI’s to the use of B-blockers. Head injury, intracranial ds, stroke  optic atrophy or visual field defects. Migraine and Raynaud phenomenon  vasospasm Diabetes, HTN and CVS ds  risk of POAG
  • 7. EXAMINATION  Visual acuity  Pupils : RAPD  SLE  Tonometry  Gonioscopy.  Optic disc examination: intrapapillary changes  Peripapillary changes : PPA, RNFL defects, Disc splinter H’ages, diameter of retinal arterioles.
  • 8. Evaluationof opticnerve head The optic disk size and shape,  Cup-to-disk (C:D) ratio in relation to the disk size, Configuration and depth of the optic cup, The configuration of the neuroretinal rim, Position of the exit of the central retinal vessel trunk, Presence and location of disk hemorrhage,  RNFL defects, and Configuration and location of parapapillary chorioretinal atrophy
  • 9. The Neuroretinal Rim • Most important parameter. • This is the ‘ISNT rule’ which helps to determine glaucomatous changes in the disc glaucoma. • On an average, the inferior rim is 18% thicker than the superior rim.* • The loss of NRR from the inner edge of the rim cardinal feature. • The sequence of loss is usually first in the inferotemporal and superotemporal disk regions. • *Arvind H, George R, Raju P, Ve RS, Mani B, Kannan P, Vijaya L. Neural rim characteristics of healthy South Indians: the Chennai Glaucoma Study. Invest Ophthalmol Vis Sci 2008 Aug;49(8): 3457-3464
  • 10.
  • 11. Optic disc haemorrhage • Splinter or flame-shaped hemorrhage, with feathered edges, oriented radially and perpendicular to the disk margin. • Location: prelaminar area of the optic disk and in the adjacent superficial RNFL. • It is located within one disk diameter from the optic disk border
  • 12. Retinal Nerve Fibre Layer • Red-free light is best for evaluation of the RNFL as the short wavelength light brings the anterior layer into better focus. • The classic localised defect of the RNFL associated with glaucoma is seen as a darkened wedge that extends from a corresponding thinning in the neuroretinal rim tissue
  • 13. Peripapillary ChorioretinalAtrophy • The peripheral alpha zone : Irregular hypo- and hyperpigmentation, associated with thinning of the chorioretinal tissue layer. • Bthe cenral beta zone : marked atrophy of the RPE and choriocapillaris and thinning of the chorioretinal tissues with good visibility of the large choroidal vessels and sclera. • If both zones are present, the beta zone is always closer to the optic disc than the alpha zone.
  • 14.
  • 15. INVESTIGATIONS • Pachymetry • Perimetry • Ocular coherence tomography(OCT): optic disc and peripapillar RNFL imaging • Fundus photograph
  • 16. DIFFERENTIAL DIAGNOSIS Other causes of increased IOP Ocular hypertension Secondary open angle glaucoma Chronic angle closure glaucoma Other causes of cupping and field defects Physiological cupping Congenital optic nerve defects Anterior ischemic optic neuropathy Primary optic atophy
  • 18. INDICATIONS 1) Classic glaucoma triad or at high risk for same. 2) Progressive cupping without detectable field loss, 3) The development of visual field loss, 4) Episodes of corneal edema caused by elevated IOP, 5) Vascular occlusion associated increased IOP. 6) C/L eye in pts with asymmetric POAG  treated aggressively  40% chance of v. field loss over a 5-year .
  • 19. GOALS To preserve good visual function for the patient’s lifetime. To preserve a reasonable quality of life and comfort.  Minimizing the side effects from the treatment, the risk of vision loss and, in many cases, the costs associated with treatment.
  • 20. TARGET PRESSURE Definition : The pressure level (range) below which further damage to the optic nerve is unlikely to occur. Choice of target IOP: It is usually 20-30 % reduction of baseline IOP but it should be individualized for each patient based on 1.Initial untreated IOP. 2.Degree of existing damage.(Optic nerve cupping, visual field loss and RNFL thickness) 3. Age of the patient (life expectancy)
  • 21. Follow-up and Resetting target IOP Target IOP is a dynamic value. The initial efficacy of therapy is determined by its effect on IOP, but long-term efficacy must be determined by the analysis of damage (visual field, the optic nerve head, retinal nerve fiber thickness). Deterioration in any of these  more aggressive T/t (i.e. to Re-set the Target intraocular pressure at a lower level) taking into consideration the other risk factors
  • 22.

Editor's Notes

  1. In the majority, but by no means all, cases the intraocular pressure (IOP) is elevated above the statistically ‘normal’ range, reflecting a reduced aqueous humor outflow facility. Although elevated IOP is not the cause of all damage in POAG, it is the major risk factor.
  2. Because many individuals with ‘elevated’ IOP never develop glaucoma, and because many people with glaucoma have ‘normal’ IOPs, IOP obviously cannot be the only risk factorThere is general agreement that IOP is the most important known risk factor for open-angle glaucoma development Conflicting information exists. In several studies, males had a higher prevalence of glaucoma. In the Barbados study, POAG was associated with older men, high IOP, positive family history. The prevalence of POAG increases with age. Although it occurs in children and young adults as well. After compensating the relationship between increasing age and increasing IOP, POAG does increase in prevalence with age Risk factor ; ocular hypertension  open-angle glaucoma. Even in normal-pressure glaucoma, asymmetric IOP has been noted to correlate with asymmetric cupping and field loss, with the greater damage most often occurring on the side with higher pressure. Among those with elevated IOP without evidence of glaucomatous damage (ocular hypertensives), the OHTS study shows that the higher the IOP, the more likely that glaucomatous damage will develop. . Myopia has been associated with POAG in many studies. Myopia  direct influence on the prevalence of the disease known associations with increased IOP and larger cup-to-disc ratios. A Thin cornea  risk factor for ocular hypertension  POAG is a marker and possible risk factor for advanced glaucoma on diagnosis.  underestimate the IOP on GAT.  marker for increased susceptibility of the optic nerve Genetic or familial component. Autosomal dominant, autosomal recessive, and sex-linked inheritance patterns. Polygenic or multifactorial transmission. 5–50%  hereditary, 4-16% risk  first degree relative. 13%  monozygotic and dizygotic twin inheritance Diabetes mellitus: affects the small blood vessels supplying the optic nerve  more susceptible to glaucomatous damage. Thyroid disease, corticosteroid function, systemic vascular disease and sleep apnea.
  3. On a routine examination a patient's intraocular pressure is found to be high. A single IOP recording of more than 21 mm Hg does not always indicate glaucoma. If the second reading is normal, and if gonioscopy, disc examination and the visual field examination are normal, then there is no evidence of glaucoma. If a repeat IOP is also high, the next step is to determine whether the pressure is raised due to angle closure glaucoma or is associated with open angles. Anytime a high IOP is recorded (including a first measurement), a gonioscopy should be done immediately. If the patient with a raised pressure has a closed angle i.e. trabecular meshwork is not visible, then a diagnosis of angle closure glaucoma is made and the treatment proceeds appropriately. If on gonioscopy the central anterior depth is found normal, but the iris has a plateau configuration, the treatment follows the flow chart for angle closure. Gonioscopy may be, however inconclusive. The angle may look suspicious but not closed, i.e. the raised IOP may (or may not) be due to closure. Angle closure is an absolute phenomenon, and may be intermittent and/or partial. Alternatively the angle may be narrow and closable, but open, in which case this may represent a combined mechanism. If the IOP is raised and the angles on gonioscopy are open, the patient should be evaluated for POAG, and the patient slots into that flow chart.
  4. The patient may be a suspect because of a raised IOP, suspicious discs, or occassionally on the basis of suspicious fields alone. If the IOP is high, the patient's disc and visual fields are evaluated. If these show glaucomatous changes, the patient has POAG. If the disc and fields are normal, and the IOP is raised, the patient fits into the "ocular hypertensive" category. Without going into the controversies surrounding this term, we prefer to call them glaucoma suspects.  If the IOP is normal and the patient is a glaucoma suspect for whatever reason, a diurnal variation of IOP (DVT) is recorded. If this shows a high peak or a large variation, the patient's disc and fields need evaluation. If the DVT is negative, the patient was probably a suspect due to disc and field criteria, and these need to be critically reevaluated. A patient with normal IOP may be a POAG suspect due to the appearance of his discs and/or visual fields. A DVT, therefore, is desirable. If the discs and fields show characteristic changes of POAG, and the IOP is normal, the diagnosis is "normotensive" glaucoma . Subsequent DVT may reveal a raised TOP, which confirms POAG. If, with a normal IOP, the disc and field show no glaucomatous changes, the diagnosis of POAG can be excluded As usual we come to our equivocal category - the disc and the visual field look suspicious, but we are not convinced. In this instance, the disc and field examination are repeated and if the same indecision prevails, additional information is needed. If the patient has risk factors for POAG, the patient is followed up and the entire work up is repeated. If we are suspicious enough we may decide to follow up those without risk factors also.
  5. Temporal vision  loss of fixation lost.
  6. Visual acuity is likely to be normal except in advanced glaucoma. Disc changes: EarlyRnFL defects, focal notching, vertical elongation of cup, Baring of circum linear vessels, splinter h’ages, assymetry of cup btwn 2 eyes Late  concentric elongation, NRR thinning, increased cupping, vertical elong, peripapillary atrophy, nasal shifting of vessels, bayonetting sign, laminar dot sign. 2 Pupils. Exclude a relative afferent pupillary defect (RAPD); if absent then subsequently develops this constitutes an indicator of substantial progression. 3 Colour vision assessment such as Ishihara chart testing if there is any suggestion of an optic neuropathy other than glaucoma. 4 Slit-lamp examination. Exclude features of secondary glaucomas such as pigmentary and pseudoexfoliative. 5 Tonometry, prior to pachymetry, noting the time of day. 6 Pachymetry for CCT. 7 Gonioscopy. 8 Optic disc examination should always be performed with the pupils dilated, provided gonioscopy does not show critically narrow angles. Red-free light can be used to detect RNFL defects. 9 Perimetry should usually be performed prior to clinical examination. 10 Optic disc or peripapillary RNFL imaging as described above
  7. Some are round and blotchy because they are situated in deeper parts of the disk and, occasionally, when the cup is large, a hemorrhage can be seen on the lamina cribrosa itself. and one should rule out presence of optic disk edema, papillitis, diabetic retinopathy, central or branch retinal vein occlusion, or any other retinal disease associated with hemorrhage
  8. Diffuse RNFL defects can also be seen in glaucoma, although they are difficult to detect with biomicroscopy
  9. Occurs more often in glaucomatous eyes than in normal eyes, or in eyes with ocular hypertension. More often seen in glaucomatous eyes with shallow cupping than in glaucomatous eyes with deep and steep excavation The alpha zone and beta zone have to be differentiated from the scleral crescent in eyes with high myopia and from the inferior scleral crescent in eyes with tilted optic discs
  10. Physiological cupping horizontally oval, symmetry btwn 2 eyes , Follows ISNT rule, cup & NRR config( both margins runs parallel) Glaucomatous cupping vertically oval, asymmetry btwn eyes, progressive cup enlargement, saucerization of cup, PPA, RNFL defects Neurological cupping NRR pallor more than obliteration, AION ( disc edema, splinter h’age), non progressive, Va and field defects out of proportion to cupping, Red green color vision lost.